Implementation of a Fast-Track Procedure: Accelerating Clinical Trial Authorisations from 2026
From the first quarter of 2026, a new national fast-track authorisation scheme will be implemented to strengthen the attractiveness of France as a research hub and to provide patients with faster and more secure access to therapeutic innovations.
The speed at which clinical trials are authorised and implemented has become a major competitiveness factor in attracting research projects. The numerous administrative delays observed so far have placed Europe—and France in particular—behind other geographical areas, even as the continent seeks to strengthen its scientific and medical leadership.
The fast-track scheme therefore aims to significantly reduce ANSM evaluation timelines, while maintaining high standards of safety and scientific rigour. It is intended for both academic and industrial sponsors.
To this end, the scheme applies exclusively to mono-national clinical trials and is primarily intended for:
To benefit from this scheme, sponsors must:
Prior eligibility verification will be carried out by the ANSM before the project evaluation process is initiated.
The European procedure provides timelines of 31 days with no questions and up to 106 days in case of clarification requests, with an additional 50 days for advanced therapy medicinal products. The French fast-track reduces these timelines to 14 days with no questions, a maximum of 49 days with clarifications, and no additional time for ATMPs.
A pilot phase will be launched upstream to test the system and optimise processes before full deployment in 2026.
However, this accelerated authorisation process does not exempt sponsors from complying with the usual regulatory requirements, namely obtaining:
The launch of the fast-track procedure in 2026 represents a major step forward for French clinical research. By significantly reducing authorisation timelines, France aims to strengthen its international attractiveness in biomedical research, increase the number of early-phase trials, and improve patient access to the most recent treatments.
Sources:
ANSM – France commits to a fast-track scheme to accelerate clinical trial authorisations
To view all our articles : https://www.dpo-consulting.com/blog
To give you 100% control over the design, together with Webflow project, you also get the Figma file. After the purchase, simply send us an email to and we will e happy to forward you the Figma file.
Yes, we know... it's easy to say it, but that's the fact. We did put a lot of thought into the template. Trend Trail was designed by an award-winning designer. Layouts you will find in our template are custom made to fit the industry after carefully made research.
We used our best practices to make sure your new website loads fast. All of the images are compressed to have as little size as possible. Whenever possible we used vector formats - the format made for the web.
Grained is optimized to offer a frictionless experience on every screen. No matter how you combine our sections, they will look good on desktop, tablet, and phone.
Both complex and simple animations are an inseparable element of modern website. We created our animations in a way that can be easily reused, even by Webflow beginners.
Our template is modular, meaning you can combine different sections as well as single elements, like buttons, images, etc. with each other without losing on consistency of the design. Long story short, different elements will always look good together.
On top of being modular, Grained was created using the best Webflow techniques, like: global Color Swatches, reusable classes, symbols and more.
Grained includes a blog, carrers and projects collections that are made on the powerful Webflow CMS. This will let you add new content extremely easily.
Grained Template comes with eCommerce set up, so you can start selling your services straight away.
To give you 100% control over the design, together with Webflow project, you also get the Figma file.
.svg)
